Overview

A Study of Aripiprazole Lauroxil (Also Known as ARISTADA TM) in Subjects With Schizophrenia

Status:
Completed
Trial end date:
2017-07-11
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety and tolerability of aripiprazole lauroxil (also known as ARISTADA, ALKS 9070).
Phase:
Phase 4
Details
Lead Sponsor:
Alkermes, Inc.
Treatments:
Aripiprazole
Aripiprazole lauroxil
Paliperidone Palmitate